The information may be unavailable due to the results not being approved or confirmed. In particular, when a call includes regions where projects are cofunded by EC funds and others where that is not the case, confirmation or approval may be not simultaneous.
Establishing anti-telomerase terapeuthics for invasive melanoma in zebrafish. Miguel Godinho Ferreira, Fundação Calouste Gulbenkian (FCG). €179,505.
Mucin MUC16 - CA125 cancer biomarker - biological functions and development of new biomarker assays. Maria Leonor Martins Soares David, Instituto de Patologia e Imunologia Molecular (IPATIMUP/UP). €165,000.
Epigenetic regulation in mammary stem/progenitor cells and its contribution to malignant transformation. Luisa Alejandra Helguero, Universidade de Aveiro (UA). €179,505.
Development of function blocking antibodies using Phage Display Technology: Inhibiton of the Notch1 signaling pathway by function blocking anti-jagged 1 antibody. Ana Barbas, Instituto de Biologia Experimental e Tecnológica (IBET). €149,505.
Investigation on the effect of Dll4Fc anti-angiogenic tumour therapy on metastatic dissemination. Alexandre José Neto Trindade, Faculdade de Medicina Veterinária (FMV/ULisboa). €149,505.
Dissecting the impact of IL7R gain-of-function mutations in T-cell leukemia. João Pedro Taborda Barata, Instituto de Medicina Molecular João lobo Antunes (IMM/FM/ULisboa). €165,000.